Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
16,695,187
-
Share change
-
-2,406,659
-
Total reported value
-
$4,290,857,456
-
Put/Call ratio
-
154%
-
Price per share
-
$257.03
-
Number of holders
-
300
-
Value change
-
-$590,317,087
-
Number of buys
-
135
-
Number of sells
-
158
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2014
As of 30 Jun 2014,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
300 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,695,187 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BANK OF AMERICA CORP /DE/, UBS AG, BARCLAYS PLC, CHURCHILL MANAGEMENT Corp, CREDIT SUISSE AG/, Mirae Asset Global Investments Co., Ltd., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
300
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.